Clinical trial
Diagnostic Accuracy of IgA Anti-transglutaminase Antibodies Measured by CLIA for Predicting Villous Atrophy in Coeliac Disease
NCT07364461 is registered in ClinicalTrials.gov with Hospital Mutua de Terrassa as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic Accuracy of IgA Anti-transglutaminase Antibodies Measured by CLIA for Predicting Villous Atrophy in Coeliac Disease
- Lead sponsor
- Hospital Mutua de Terrassa
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- December 31, 2025
- Enrollment
- 765 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coeliac disease